COMMUNIQUÉS West-GlobeNewswire

Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
14/05/2026
MELBOURNE, Australia , May 13, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, [...]
Fangzhou and Tenry Pharmaceutical Forge Strategic Partnership to Advance AI-Powered Chronic Disease Care
14/05/2026
SHANGHAI, May 14, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, and Shanghai Tenry Pharmaceutical Co., Ltd. (“Tenry [...]
JellyTide Claims Evaluated: The Gelatin Trick Recipe + Baking Soda Shot with Lemon for Weight Loss Using Jelly Tide Gummies
14/05/2026
JellyTide Scam or Legit? BHB Salts, Apple Cider Vinegar Gummies, Side Effects, Dosage, and 60-Day Guarantee Explained Largo, FL, May 13, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and [...]
Memopezil Under Investigation: Evaluating the Claims, Risks and Hidden Official Website Complaints about the Natural Donepezil Cocoa and Honey Protocol
14/05/2026
Bacopa Monnieri, Rhodiola Rosea, L-Theanine, and Panax Ginseng in Memopezil Supplement Facts, Refund Policy, Ingredients, and Cognitive Support Claims Explained Largo, FL, May 13, 2026 (GLOBE NEWSWIRE) -- These [...]
Rapid Micro Biosystems Reports First Quarter 2026 Financial Results
13/05/2026
Reports first quarter 2026 total revenue of $8.0 million , representing 11% growth compared to the first quarter of 2025 Placed 6 Growth Direct systems in the first quarter 2026 compared to 3 systems in the first [...]
SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates
13/05/2026
Added 7 top-rated children’s hospitals to QUELIMMUNE ® pediatric acute kidney injury (AKI) customer base, increasing first quarter revenue 69% versus first quarter 2025 revenue Advanced enrollment in the NEUTRALIZE-AKI [...]
Combined General Meeting of June 3, 2026
13/05/2026
Châtillon, France, May 13, 2026 Combined General Meeting of June 3, 2026 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: [...]
Precision Optics Reports Third Quarter Fiscal Year 2026 Financial Results
13/05/2026
Conference Call Scheduled for today, May 13, 2026, at 5:00pm ET LITTLETON, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced [...]
ZyVersa Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
13/05/2026
ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible market >$100 billion. Inflammasome ASC Inhibitor IC 100 is the next evolution of inflammasome [...]
Venus Concept Announces Senior Management Changes
13/05/2026
TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced changes to its senior leadership team. Kirk Gunhus, Chief [...]
Management team’s 2025 market-based Options have vested
13/05/2026
Share price increase from $6 to $30 triggers full vesting NEW HAVEN, Conn., May 13, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that 2025 employee stock options [...]
Hard Chews Gummies Claims Evaluated: Investigating the Salt Tonic Trick Recipe for Men
14/05/2026
Hard Chews Gummies Ingredients, Male Performance Support, L-Arginine, Tongkat Ali, Maca Root, 180-Day Guarantee, Pricing, and Subscribe and Save Researched Aurora, CO, May 13, 2026 (GLOBE NEWSWIRE) -- These statements [...]
Aptose Reports First Quarter 2026 Results
13/05/2026
SAN DIEGO and TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS)-based [...]
Park Dental Partners Announces First Quarter 2026 Results
13/05/2026
MINNEAPOLIS, May 13, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its first-quarter [...]
Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
13/05/2026
First clinical data from PRMT5/RAS(ON) combination trial to be pre sented in 2026 Cash position of $380 million as of March 31, 2026, with runway into 2028 beyond anticipated key data inflection points BOSTON, May 13, [...]
Bionano Reports First Quarter 2026 Results and Provides a Business Update
13/05/2026
Conference call today, May 13, 2026, at 4:30 PM ET SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. "The [...]
Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights
13/05/2026
- Composition of matter provisional patent application filed for a new form of brilaroxazine designed to extend patent life and commercial exclusivity through 2046 - - FDA feedback on use of new form of brilaroxazine in [...]
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
13/05/2026
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as [...]
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
13/05/2026
Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026 $28 million in cash, cash equivalents, restricted cash [...]

Pages